The CINRYZESolutions® Programs

The CINRYZESolutions Programs were created to help people who are prescribed CINRYZE® (C1 esterase inhibitor [human]). Once enrolled, you will gain access to the Patient Service Center (PSC), your resource for financial support, answers to insurance questions, and assistance with coordinating your care.

To help you start coordinating your CINRYZE therapy, the PSC is available to:

  • Help explain your insurance benefits and coverage
  • Answer questions about open enrollment to help you understand other benefit choices
  • Work with insurance plans on your behalf
  • Provide information about financial services available for eligible patients, such as financial services for therapy-related expenses, nursing costs, diagnostic lab tests, and transportation for infusions
  • Provide information about available co-pay programs
  • Help locate a site of care, or a place where you will receive your infusion
  • Coordinate self-administration training for appropriate patients

CINRYZESolutions also includes three programs for people with HAE:

The CINRYZESolutions team set us up with a home-health nurse who trained Jason and I on the process of how to infuse. Self-administration is part of our life together. quote


Lauren

Wife, mother, trained to self-administer CINRYZE

 

Do not attempt to self-administer unless you have been taught how by your healthcare provider.

To learn more about what the CINRYZESolutions Programs can do for you, we encourage you to speak with a Patient Care Coordinator at
1-877-945-1000 (toll-free) or send an email to inquiries@cinryzesolutions.com. CINRYZESolutions is available Monday through Friday, 8:00 am to 7:00 pm EST.

You may also download the
CINRYZESolutions brochure to learn more.

Administration Options

The Path to Independence Program is a complimentary service for eligible patients.

Read more ›

Stories, Tools, and Resources

Get all these and more with the Ryze Above Program.

Learn more ›

Indication
CINRYZE® (C1 esterase inhibitor [human]) is an injectable prescription medicine that is used to help prevent swelling and/or painful attacks in teenagers and adults with Hereditary Angioedema (HAE).

Important Safety Information
You should not use CINRYZE if you have had life-threatening immediate hypersensitivity reactions, including anaphylaxis to the product.

Tell your healthcare provider about all of your medical conditions, including if you:

  • have an indwelling catheter/access device in one of your veins.
  • have a history of blood clots, heart disease, or stroke.
  • are taking birth control pills or androgens.
  • Are pregnant or planning to become pregnant. It is not known if CINRYZE can harm your unborn baby.
  • Are breastfeeding or plan to breastfeed. It is not known if CINRYZE passes into your milk and if it can harm your baby.

Tell your healthcare provider and pharmacist about all of the medicines you take, including all prescription and non-prescription medicines such as over-the-counter medicines, supplements, or herbal remedies.

Allergic reactions may occur with CINRYZE. Call your healthcare provider or get emergency support services right away if you have any of the following symptoms:

  • wheezing
  • difficulty breathing
  • chest tightness
  • turning blue (look at lips and gums)
  • fast heartbeat
  • swelling of the face
  • faintness
  • rash
  • hives

Serious blood clots may occur with CINRYZE. Call your healthcare provider or get emergency support services right away if you have any of the following symptoms:

  • pain and/or swelling of an arm or leg with warmth over the affected area
  • discoloration of an arm or leg
  • unexplained shortness of breath
  • chest pain or discomfort that worsens on deep breathing
  • unexplained rapid heart rate
  • numbness or weakness on one side of the body

Because CINRYZE is made from human blood, it may carry a risk of transmitting infectious agents, e.g., viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent.

The most common side effects seen with CINRYZE were headache, nausea, rash, and vomiting. These are not all the possible side effects of CINRYZE. Tell your healthcare provider about any side effect that bothers you or that does not go away. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. You can also report side effects to ViroPharma Medical Information at (866) 331-5637.

Medicines are sometimes prescribed for purposes other than those listed here. Do not use CINRYZE for a condition for which it is not prescribed. Do not share CINRYZE with other people, even if they have the same symptoms that you have.

Before starting CINRYZE, please read the accompanying Patient Information carefully and each time you get a refill. This information does not take the place of talking with your healthcare provider, and it does not include all of the important information about CINRYZE. If you have questions after reading this, ask your healthcare provider.

Please see the Full Prescribing Information.

Was this content
 useful to you?